Literature DB >> 23083748

Epidemiology of spondyloarthritis.

Carmen Stolwijk1, Annelies Boonen, Astrid van Tubergen, John D Reveille.   

Abstract

Spondyloarthritis (SpA) represents a group of interrelated diseases with common clinical features and a close association with HLA-B27. Reports of incidence and prevalence of diseases vary depending on methodological differences between studies, the case definition used to classify disease, and the prevalence of HLA-B27 in the population studied. Newly proposed criteria for axial SpA and peripheral SpA present a new approach to facilitate classification of the SpA into 2 main subtypes and the criteria allow earlier detection of patents with inflammatory back pain. These criteria were developed for use in a (specialized) clinical setting and not for large epidemiologic studies.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23083748      PMCID: PMC4470267          DOI: 10.1016/j.rdc.2012.09.003

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  127 in total

1.  Assessing risk of bias in prevalence studies: modification of an existing tool and evidence of interrater agreement.

Authors:  Damian Hoy; Peter Brooks; Anthony Woolf; Fiona Blyth; Lyn March; Chris Bain; Peter Baker; Emma Smith; Rachelle Buchbinder
Journal:  J Clin Epidemiol       Date:  2012-06-27       Impact factor: 6.437

2.  Development quality criteria to evaluate nontherapeutic studies of incidence, prevalence, or risk factors of chronic diseases: pilot study of new checklists.

Authors:  Tatyana A Shamliyan; Robert L Kane; Mohammed T Ansari; Gowri Raman; Nancy D Berkman; Mark Grant; Gail Janes; Margaret Maglione; David Moher; Mona Nasser; Karen A Robinson; Jodi B Segal; Sophia Tsouros
Journal:  J Clin Epidemiol       Date:  2010-11-11       Impact factor: 6.437

3.  Prevalence of axial spondylarthritis in the United States: estimates from a cross-sectional survey.

Authors:  John D Reveille; James P Witter; Michael H Weisman
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-01-24       Impact factor: 4.794

Review 4.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review.

Authors:  Natalie A Molodecky; Ing Shian Soon; Doreen M Rabi; William A Ghali; Mollie Ferris; Greg Chernoff; Eric I Benchimol; Remo Panaccione; Subrata Ghosh; Herman W Barkema; Gilaad G Kaplan
Journal:  Gastroenterology       Date:  2011-10-14       Impact factor: 22.682

5.  Prevalence of spondyloarthritis and its subtypes in southern Sweden.

Authors:  E Haglund; A B Bremander; I F Petersson; B Strömbeck; S Bergman; L T H Jacobsson; A Turkiewicz; P Geborek; M Englund
Journal:  Ann Rheum Dis       Date:  2011-02-02       Impact factor: 19.103

6.  Incidence of psoriatic arthritis in Finland.

Authors:  O Kaipiainen-Seppänen
Journal:  Br J Rheumatol       Date:  1996-12

Review 7.  Reactive arthritis.

Authors:  Timo Hannu
Journal:  Best Pract Res Clin Rheumatol       Date:  2011-06       Impact factor: 4.098

8.  The prevalence of HLA-B27 in the US: data from the US National Health and Nutrition Examination Survey, 2009.

Authors:  John D Reveille; Rosemarie Hirsch; Charles F Dillon; Margaret D Carroll; Michael H Weisman
Journal:  Arthritis Rheum       Date:  2012-05

9.  The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients.

Authors:  Maxime Dougados; Maria-Antonietta d'Agostino; Joëlle Benessiano; Francis Berenbaum; Maxime Breban; Pascal Claudepierre; Bernard Combe; Patricia Dargent-Molina; Jean-Pierre Daurès; Bruno Fautrel; Antoine Feydy; Philippe Goupille; Véronique Leblanc; Isabelle Logeart; Thao Pham; Pascal Richette; Christian Roux; Martin Rudwaleit; Alain Saraux; Jean-Marc Treluyer; Désirée van der Heijde; Daniel Wendling
Journal:  Joint Bone Spine       Date:  2011-03-31       Impact factor: 4.929

10.  HLA-B27 Prevalence in Arab Populations and Among Patients with Ankylosing Spondylitis.

Authors:  Khader N Mustafa; Mohammed Hammoudeh; Muhammad Asim Khan
Journal:  J Rheumatol       Date:  2012-07-01       Impact factor: 4.666

View more
  47 in total

Review 1.  Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases.

Authors:  Gergely Bodis; Victoria Toth; Andreas Schwarting
Journal:  Rheumatol Ther       Date:  2018-03-07

2.  Potential risk factors for reactive arthritis and persistence of symptoms at 2 years: a case-control study with longitudinal follow-up.

Authors:  Helga Raquel Garcia Ferrer; Alexander Azan; Isa Iraheta; Joan Von Feldt; Luis R Espinoza; Julia Manasson; Jose U Scher; Abraham Garcia Kutzbach; Alexis Ogdie
Journal:  Clin Rheumatol       Date:  2017-11-14       Impact factor: 2.980

Review 3.  Immune checkpoint inhibitor-induced inflammatory arthritis as a model of autoimmune arthritis.

Authors:  Laura C Cappelli; Mekha A Thomas; Clifton O Bingham; Ami A Shah; Erika Darrah
Journal:  Immunol Rev       Date:  2020-01-13       Impact factor: 12.988

Review 4.  Nonradiographic axial spondyloarthritis background and confounding factors of this new terminology: an appraisal.

Authors:  Jen Erbil; Luis R Espinoza
Journal:  Clin Rheumatol       Date:  2014-10-01       Impact factor: 2.980

Review 5.  The changing clinical picture and epidemiology of spondyloarthritis.

Authors:  Astrid van Tubergen
Journal:  Nat Rev Rheumatol       Date:  2014-11-11       Impact factor: 20.543

Review 6.  Beyond the TNF-α Inhibitors: New and Emerging Targeted Therapies for Patients with Axial Spondyloarthritis and their Relation to Pathophysiology.

Authors:  Susanne Juhl Pedersen; Walter P Maksymowych
Journal:  Drugs       Date:  2018-09       Impact factor: 9.546

7.  Association of obesity with patient-reported outcomes in patients with axial spondyloarthritis: a cross-sectional study in an urban Asian population.

Authors:  Yi Xuan Lee; Yu Heng Kwan; Wan Yu Png; Ka Keat Lim; Chuen Seng Tan; Nai Lee Lui; Eng Hui Chew; Julian Thumboo; Truls Østbye; Warren Fong
Journal:  Clin Rheumatol       Date:  2017-04-04       Impact factor: 2.980

Review 8.  The Pathogenesis of Ankylosing Spondylitis: an Update.

Authors:  Susanne Juhl Pedersen; Walter P Maksymowych
Journal:  Curr Rheumatol Rep       Date:  2019-11-11       Impact factor: 4.592

Review 9.  Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis).

Authors:  Féline P B Kroon; Lennart R A van der Burg; Sofia Ramiro; Robert B M Landewé; Rachelle Buchbinder; Louise Falzon; Désirée van der Heijde
Journal:  Cochrane Database Syst Rev       Date:  2015-07-17

10.  Prevalence of Rheumatoid Arthritis and Spondyloarthritis in Turkey: A Nationwide Study.

Authors:  Tiraje Tuncer; Erdal Gilgil; Cahit Kaçar; Yeşim Kurtaiş; Şehim Kutlay; Bülent Bütün; Peyman Yalçin; Ülkü Akarirmak; Lale Altan; Füsun Ardiç; Özge Ardiçoğlu; Zuhal Altay; Ferhan Cantürk; Lale Cerrahoğlu; Remzi Çevik; Hüseyin Demir; Berrin Durmaz; Nigar Dursun; Tuncay Duruöz; Canan Erdoğan; Deniz Evcik; Savaş Gürsoy; Sami Hizmetli; Ece Kaptanoğlu; Önder Kayhan; Mehmet Kirnap; Siranuş Kokino; Erkan Kozanoğlu; Banu Kuran; Kemal Nas; Sema Öncel; Dilşad Sindel; Sevim Orkun; Tunay Sarpel; Serpil Savaş; Ömer Faruk Şendur; Kazım Şenel; Hatice Uğurlu; Kaan Uzunca; İbrahim Tekeoğlu; Francis Guillemin
Journal:  Arch Rheumatol       Date:  2017-10-13       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.